Ruby Shalom‐Feuerstein
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Corneal Surgery and Treatments
- Corneal surgery and disorders
Papers in
-
- RNA Research and Splicing 5
- Pluripotent Stem Cells Research 4
- Developmental Biology and Gene Regulation 4
-
- Corneal Surgery and Treatments 12
- Corneal surgery and disorders 8
- Co-authors
- Daniel Aberdam (13 shared papers)Gerry Melino (6 shared papers)Eleonora Candi (5 shared papers)Richard A. Knight (4 shared papers)Anna Maria Lena (4 shared papers)Pia Rivetti di Val Cervo (1 shared paper)Aya Amitai-Lange (9 shared papers)Yoel Kloog (4 shared papers)
- Journals
- Stem Cells (3 papers)Stem Cell Reports (3 papers)Proceedings of the National Academy of Sciences (2 papers)Cancer Research (2 papers)Cell Death and Disease (2 papers)
- Partner nations
- IsraelFranceUnited Kingdom
In The Last Decade
Ruby Shalom‐Feuerstein
29 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 484
- Radiology, Nuclear Medicine and Imaging 398
- Molecular Biology 957
- Oncology 297
- Developmental Neuroscience 44
Countries citing papers authored by Ruby Shalom‐Feuerstein
This map shows the geographic impact of Ruby Shalom‐Feuerstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Shalom‐Feuerstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Shalom‐Feuerstein more than expected).
Fields of papers citing papers by Ruby Shalom‐Feuerstein
This network shows the impact of papers produced by Ruby Shalom‐Feuerstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Shalom‐Feuerstein. The network helps show where Ruby Shalom‐Feuerstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruby Shalom‐Feuerstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 333 | |
| 2 | 2011 | 161 | |
| 3 | 2008 | 116 | |
| 4 | 2010 | 115 | |
| 5 | 2010 | 111 | |
| 6 | 2021 | 109 | |
| 7 | 2012 | 105 | |
| 8 | 2014 | 102 | |
| 9 | 2005 | 90 | |
| 10 | 2018 | 85 | |
| 11 | 2012 | 77 | |
| 12 | 2015 | 67 | |
| 13 | 2013 | 61 | |
| 14 | 2021 | 53 | |
| 15 | 2017 | 44 | |
| 16 | 2018 | 38 | |
| 17 | 2016 | 22 | |
| 18 | 2018 | 20 | |
| 19 | 2008 | 19 | |
| 20 | 2022 | 15 |
About Ruby Shalom‐Feuerstein
Ruby Shalom‐Feuerstein is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Public Health, Environmental and Occupational Health and Cell Biology, having authored 29 papers that have together received 1.8k indexed citations. Recurring topics across this work include Corneal Surgery and Treatments (12 papers), Corneal surgery and disorders (8 papers), Ocular Surface and Contact Lens (6 papers), RNA Research and Splicing (5 papers), MicroRNA in disease regulation (5 papers), Pluripotent Stem Cells Research (4 papers), Developmental Biology and Gene Regulation (4 papers) and Galectins and Cancer Biology (3 papers). The work is most often cited by research in Cancer Research (484 citations), Radiology, Nuclear Medicine and Imaging (398 citations), Molecular Biology (957 citations), Oncology (297 citations) and Developmental Neuroscience (44 citations). Ruby Shalom‐Feuerstein has collaborated with scholars based in Israel, France and United Kingdom. Frequent co-authors include Daniel Aberdam, Gerry Melino, Eleonora Candi, Richard A. Knight, Anna Maria Lena, Pia Rivetti di Val Cervo, Aya Amitai-Lange, Yoel Kloog, Beatrice Tiosano and Anna Altshuler. Their work appears in journals such as Stem Cells, Stem Cell Reports, Proceedings of the National Academy of Sciences, Cancer Research and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.